Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity
Alicia Amadoz(TiGenix (Spain)), Joaquı́n Dopazo(Fundación Progreso y Salud), Francisco Salavert(Centre for Biomedical Network Research on Rare Diseases), Patricia Sebastián-León(Centro de Investigacion Principe Felipe), Enrique Vidal(Leitat Technological Center)
Cited by 62
Related Papers
Differential expression in RNA-seq: A matter of depth
|Genome Research|2011|1.7k
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
|Nature Biotechnology|2014|1.1k
Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming
|Nature Genetics|2018|385
The effects of death and post-mortem cold ischemia on human tissue transcriptomes
|Nature Communications|2018|338
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
|Genome biology|2016|226